Click it and Unblock the Notifications
Dr. Agarwals Health Care Ltd. IPO
IPO Timeline
-
29 Jan 2025Bidding Starts
-
31 Jan 2025Bidding Ends
-
3 Feb 2025Allotment Finalization
-
5 Feb 2025Listing
About Dr. Agarwals Health Care Ltd.
We provide a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lens and accessories, and eye care related pharmaceutical products. We endeavour to address all the needs of our patients in their eye treatment journey through a network, which as of September 30, 2024, comprised 209 Facilities.
Dr. Agarwals Health Care Ltd. IPO Reservation
| Investors Category | Shares Offered |
|---|---|
| Anchor Investors | 2,17,78,799 (28.92%) |
| Employee Reserved | 15,79,399 (2.1%) |
| Non Institutional Investors | 1,08,89,400 (14.46%) |
| Qualified Institutional Buyers (QIBs) | 1,45,19,200 (19.28%) |
| Retail Individual Investors (RIIs) | 2,54,08,599 (33.74%) |
| Shareholder Reservation | 11,29,574 (1.5%) |
Dr. Agarwals Health Care Ltd. Financial Information
| Year End | Revenue | PAT | Reserves & Surplus |
|---|---|---|---|
| 31 Mar 2025 | 1,097.70 Cr | 35.93 Cr | 1,902.05 Cr |
| 31 Mar 2024 | 882.34 Cr | 33.12 Cr | 1,217.85 Cr |
| 31 Mar 2023 | 615.34 Cr | 60.79 Cr | 553.63 Cr |
Dr. Agarwals Health Care Ltd. Background
-
2010Incorporation of our Company.
Entry into the Telangana (formerly a part of Andhra Pradesh) and Karnataka markets by entering into lease agreements for setting up eye clinics.
-
2011Investment by EILSF SPV 3 in our Company.
-
2012Entry into the Africa market by entering into an agreement with Dr, Amelia Buque to jointly promote eye hospitals and other health care related services in Mozambique.
-
2017Entry into the Maharashtra market through the acquisition of hospital facilities in Maharashtra.
-
2019Investment by Claymore Investments (Mauritius) Pte. Ltd., an indirect wholly owned subsidiary of Temasek Holdings (Private) Limited and Value Growth Investment Holdings Pte. Ltd in our Company through subscription of equity shares.
Subscription of NCDs by British International Investment (formerly known as CDC Group PLC) in our Company.
-
2021Our Company launched its 100th eye care facility.
-
2022Investment by TPG Capital’s Hyperion Investments Pte. Ltd. and Arvon Investments Pte. Ltd., an indirect wholly owned subsidiary of Temasek Holdings (Private) Limited in our Company through subscription of equity shares.
Entry into the Jammu market through the acquisition of Dr. Sood eye care practices from Dr. Rohan and Raj Deep Sood.
Strengthened presence in the Gujarat market through acquisition of the eye care business from Prizma Eyecare LLP, Dr. Sanjay Vallabhai Savani and Dr. Ashish P. Gusani
-
2023Strengthened presence in the Punjab market through the acquisition of Punjab Eye Hospital from Dr. Gurpal Singh
-
2024Entry in the Uttar Pradesh market through the acquisition of an eye care business in Varanasi.
Expanded our presence in Punjab market by acquisition of Dr Thind Eye Care Private Limited.
1. Repayment/prepayment, in part or full, of certain of our borrowings
2. General corporate purposes and unidentified inorganic acquisition
| Pricing Details | BSE | NSE |
|---|---|---|
| Issue Price | ₹ 402.00 | ₹ 402.00 |
| Open | ₹ 396.90 | ₹ 402.00 |
| Low | ₹ 370.10 | ₹ 370.20 |
| High | ₹ 412.75 | ₹ 412.90 |
| Last Trade | ₹ 401.55 | ₹ 401.65 |
1. Dr. Amar Agarwal
2. Dr. Athiya Agarwal
3. Dr. Adil Agarwal
4. Dr. Anosh Agarwal
5. Dr. Ashvin Agarwal
6. Dr. Ashar Agarwal
7. Dr. Amar Agarwal Family Trust
8. Dr. Adil Agarwal Family Trust
9. Dr. Anosh Agarwal Family Trust
10. Dr. Ashvin Agarwal Family Trust
11. Dr. Ashar Agarwal Family Trust
12. Dr. Agarwal’s Eye Institute
13. Dr. Agarwal's Eye Institute Private Limited
According to the CRISIL MI&A Report, the eye care market in India has grown at a compounded annual growth rate of 11.5% between the Financial Years 2019 and 2024 to reach the value of ?378 billion in the Financial Year 2024. This market includes surgical and non-surgical treatments for ... Read more
Phone no:43787777
FAQs
When does Dr. Agarwals Health Care Ltd. IPO opens and closes?
Dr. Agarwals Health Care Ltd. IPO opens from 29th January to 31st January 2025.What is the size of Dr. Agarwals Health Care Ltd. IPO?
The size of the Dr. Agarwals Health Care Ltd. IPO is ₹3,027.26 Cr.What is the price range of Dr. Agarwals Health Care Ltd. IPO?
The price range of Dr. Agarwals Health Care Ltd. IPO is at ₹382 to ₹402 per share.What is the minimum investment and lot size required for the Dr. Agarwals Health Care Ltd. IPO?
The minimum investment required is ₹14,070 and minimum lot size is 35 shares.When is Dr. Agarwals Health Care Ltd. IPO listing date?
The Dr. Agarwals Health Care Ltd. IPO will be listed on 5th February 2025.What is the objective of Dr. Agarwals Health Care Ltd. IPO?
1. Repayment/prepayment, in part or full, of certain of our borrowings2. General corporate purposes and unidentified inorganic acquisition
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
Sign in with Google